These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2227069)

  • 1. Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer.
    Aravantinos D; Michalas S; Papazefkos V; Christoforaki M; Stypsaneli A; Vlachos G; Athanasiadis P
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):265-70. PubMed ID: 2227069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation.
    Mogensen O; Mogensen B; Jakobsen A; Sell A
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1835-7. PubMed ID: 3220081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of RIS with the 131I-OC 125 F(ab')2 Mab and CT scan prior to second look operation for ovarian cancer.
    Papazefkos V; Michalas S; Papantoniou V; Datseris J; Athanasiadis P; Akrivos T; Leonti A; Xygakis A; Aravantinos D
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):271-7. PubMed ID: 2227070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
    Meden H; Rath W; Ohlmeyer D
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer.
    Prayer L; Kainz C; Kramer J; Stiglbauer R; Schurawitzki H; Baldt M; Schima W; Poelzleitner D; Reinthaller A; Koelbl H
    J Comput Assist Tomogr; 1993; 17(4):626-32. PubMed ID: 8331235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Computed tomography and tumor markers as diagnostic alternatives to second-look surgery in the treatment of malignant ovarian tumors].
    La Fianza A; Campani R; Dore R; Babilonti L; Torretta L
    Radiol Med; 1992 Apr; 83(4):374-82. PubMed ID: 1603993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
    Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
    Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum 125Ca levels: does the result preclude second look?
    Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM
    Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
    Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
    J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings].
    Meden H; Rath W; Teichmann A; Kuhn W
    Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer.
    Sugiyama T; Nishida T; Komai K; Nishimura H; Yakushiji M; Nishimura H
    Int J Gynaecol Obstet; 1996 Sep; 54(3):251-6. PubMed ID: 8889633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR; Tadros GH; Foemmel R; Shebes M
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
    Rose PG; Terrien JM; Baker S
    J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients.
    Pectasides D; Kayianni H; Facou A; Bobotas N; Barbounis V; Zis J; Athanassiou A
    Am J Clin Oncol; 1991 Dec; 14(6):457-62. PubMed ID: 1957833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
    Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
    Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.
    Gallion HH; Hunter JE; van Nagell JR; Averette HE; Cain JM; Copeland LJ; Higgins RV; Husseinzadeh N; Nahhas WA; Partridge EE
    Gynecol Oncol; 1992 Jul; 46(1):29-32. PubMed ID: 1634137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1992 Jun; 45(3):323-8. PubMed ID: 1612511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of multiple tumor marker assays in second-look procedures for ovarian cancer.
    Benedetti Panici P; Scambia G; Baiocchi G; Iacobelli S; Mancuso S
    Gynecol Oncol; 1989 Dec; 35(3):286-9. PubMed ID: 2599461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 125 serum levels correlated with second-look operations among ovarian cancer patients.
    Berek JS; Knapp RC; Malkasian GD; Lavin PT; Whitney C; Niloff JM; Bast RC
    Obstet Gynecol; 1986 May; 67(5):685-9. PubMed ID: 3457330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.